Avidity Partners Management’s Eli Lilly LLY Stock Holding History

Avidity Partners Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-70,000	Closed	-$54.5M	–	99
2024 Q1	$54.5M	Sell	70,000 -15,000	-18%	-$10.7M	1.76%	20
2023 Q4	$49.5M	Buy	85,000 +10,000	+13%	+$5.84M	1.81%	22
2023 Q3	$40.3M	Sell	75,000 -58,000	-44%	-$29.9M	1.62%	24
2023 Q2	$62.4M	Buy	+133,000	New	+$55.8M	2.18%	13
2023 Q1	–	Sell	-217,000	Closed	-$79.4M	–	89
2022 Q4	$79.4M	Sell	217,000 -790,000	-78%	-$280M	1.72%	20
2022 Q3	$326M	Buy	1,007,000 +397,000	+65%	+$126M	6.62%	1
2022 Q2	$198M	Buy	+610,000	New	+$183M	4.54%	6
2022 Q1	–	Sell	-344,800	Closed	-$95.2M	–	101
2021 Q4	$95.2M	Buy	344,800 +14,800	+4%	+$3.75M	2.02%	19
2021 Q3	$76.2M	Sell	330,000 -235,500	-42%	-$58.1M	1.69%	18
2021 Q2	$130M	Buy	+565,500	New	+$114M	3.51%	4
2021 Q1	–	Sell	-810,500	Closed	-$137M	–	112
2020 Q4	$137M	Buy	+810,500	New	+$121M	4.44%	4

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Avidity Partners Management's LLY Position: Q2 2024 in Review

Avidity Partners Management sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 70,000 shares — an estimated $54.5M sold.

Avidity Partners Management first reported a position in LLY in Q4 2020 and held it in 11 quarters. The position peaked at $326M in Q3 2022. 3,569 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

Avidity Partners Management reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
Avidity Partners Management sold 70,000 Eli Lilly shares in Q2 2024, an estimated $54.5M.
Avidity Partners Management first reported a position in Eli Lilly in Q4 2020 and held it in 11 quarters.
Avidity Partners Management's Eli Lilly position peaked at $326M in Q3 2022.
3,569 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Avidity Partners Management's 13F filing for Q2 2024, filed 14 Aug 2024.